MedTrace Logo

Challenging the Endocannabinoid System in Sleep Restricted Healthy Volunteers to Modulate Physiological Arousal (CANISLEEP) Study

NCT07656350 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-06-18

No results posted yet for this study

Summary

The goal of this study is to learn about the body's response to cannabis based products in sleep deprived people who are currently experiencing anxiety but are otherwise healthy.

Conditions

  • Healthy Volunteer

Interventions

DRUG

THC

2.5mg tetrahydrocannabinol oil

DRUG

CBD

300mg cannabidiol oil

DRUG

THC + CBD

2.5mg THC + 300mg CBD

DRUG

Placebo

Placebo oil

Sponsors & Collaborators

Principal Investigators

  • Will Lawn, PhD · King's College London

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-02
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07656350 on ClinicalTrials.gov